Yihui Guan

发表

Comparison of [

Jun Zhao, Y. Guan, Jun Zhao, 2021 .

Dopaminergic damage pattern predicts phenoconversion time in isolated rapid eye movement sleep behavior disorder.

B. Shan, B. Nie, Kuangyu Shi, 2023, European journal of nuclear medicine and molecular imaging.

Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET

Kuangyu Shi, R. Ni, Qi Huang, 2023, bioRxiv.

Assessment of PD-L1 Expression in Non-Small Cell Lung Cancers Using [68Ga]Ga-DOTA-WL12 PET/CT.

Hao Wang, Weijun Wei, Yihui Guan, 2024, Small methods.

Preclinical development of novel PD-L1 tracers and first-in-human study of [68Ga]Ga-NOTA-RW102 in patients with lung cancers

J. Engle, Weijun Wei, Muhsin H Younis, 2024, Journal for ImmunoTherapy of Cancer.

Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [18F]Florzolotau PET imaging and subtype/stage inference algorithm

Huiwei Zhang, J. Ge, Yilin Tang, 2023, EBioMedicine.

Neurobiology of Aging

F. Xie, Ying Wang, Xiaoming Wang, 2023 .

Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease

Qi Huang, F. Xie, Joanna M. Wardlaw, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Edinburgh Research Explorer Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease

Qi Huang, Joanna M. Wardlaw, Yihui Guan, 2022 .

Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer’s disease

Qi Huang, Tao Sun, Mengci Li, 2024, Nature communications.

ImmunoPET imaging of Trop2 in patients with solid tumours

Weijun Wei, You Zhang, Lianghua Li, 2024, EMBO molecular medicine.

Verifying and refining early statuses in Alzheimer's disease progression: a possibility from deep feature comparison.

Mianxin Liu, Lin Huang, Qi Huang, 2023, Cerebral cortex.